source
- Federal AI Initiative Aims to Improve Chronic Heart Failure Care, Pending Doctor and Patient AcceptanceA new federal program will test artificial‑intelligence tools in the management of chronic heart‑failure patients. The initiative is designed to explore how AI can support diagnosis, monitoring and…
- Lexeo Therapeutics acquires Mantle Therapeutics for $8.3M to expand Friedreich ataxia pipelineLexeo Therapeutics announced it will acquire Mantle Therapeutics for an upfront payment of $8.3 million, aiming to broaden its Friedreich ataxia pipeline. The transaction could rise to $21.3 milli…